We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
-2.08%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$777M
AUM Growth
+$334M
Cap. Flow
+$396M
Cap. Flow %
50.94%
Top 10 Hldgs %
6.27%
Holding
1,320
New
618
Increased
231
Reduced
124
Closed
347

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$7M
2
CLF icon
Cleveland-Cliffs
CLF
+$6.43M
3
TPG icon
TPG
TPG
+$5.71M
4
F icon
Ford
F
+$5.07M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.99M

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$2.55M
2
HON icon
Honeywell
HON
+$2.51M
3
LEN icon
Lennar Class A
LEN
+$2.39M
4
AVGO icon
Broadcom
AVGO
+$2.24M
5
EOG icon
EOG Resources
EOG
+$2.17M

Sector Composition

Rank Sector Weight
1 Financials 17.64%
2 Technology 17.26%
3 Industrials 13.44%
4 Healthcare 12.8%
5 Consumer Discretionary 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCI icon
1051
Donaldson
DCI
$10.4B
-7,779
Closed -$690K
DDOG icon
1052
Datadog
DDOG
$90.7B
-4,151
Closed -$564K
DDS icon
1053
Dillards
DDS
$8.87B
-490
Closed -$297K
DECK icon
1054
Deckers Outdoor
DECK
$14.4B
-8,782
Closed -$910K
DELL icon
1055
Dell
DELL
$261B
-7,524
Closed -$947K
DGX icon
1056
Quest Diagnostics
DGX
$23B
-2,550
Closed -$443K
DHI icon
1057
D.R. Horton
DHI
$41.1B
-5,927
Closed -$854K
DINO icon
1058
HF Sinclair
DINO
$16.3B
-40,690
Closed -$1.87M
DK icon
1059
Delek US
DK
$4.12B
-20,957
Closed -$622K
DLB icon
1060
Dolby
DLB
$4.79B
-11,388
Closed -$731K
DMAC icon
1061
DiaMedica Therapeutics
DMAC
$378M
-12,070
Closed -$96.1K
DNA icon
1062
Ginkgo Bioworks
DNA
$515M
-11,997
Closed -$99.7K
DOLE icon
1063
Dole
DOLE
$1.36B
-12,855
Closed -$193K
DOV icon
1064
Dover
DOV
$28.2B
-5,099
Closed -$996K
DOW icon
1065
Dow Inc
DOW
$22B
-16,117
Closed -$377K
DOX icon
1066
Amdocs
DOX
$5.65B
-9,412
Closed -$758K
DRS icon
1067
Leonardo DRS
DRS
$11.8B
-44,872
Closed -$1.53M
DRVN icon
1068
Driven Brands
DRVN
$2.43B
-36,490
Closed -$541K
DSGN icon
1069
Design Therapeutics
DSGN
$741M
-11,728
Closed -$110K
DTE icon
1070
DTE Energy
DTE
$30.4B
-7,952
Closed -$1.03M
DXCM icon
1071
DexCom
DXCM
$29.2B
-13,915
Closed -$924K
DY icon
1072
Dycom Industries
DY
$12.3B
-964
Closed -$326K
ELF icon
1073
e.l.f. Beauty
ELF
$4.69B
-8,816
Closed -$670K
ENOV icon
1074
Enovis
ENOV
$1.54B
-13,253
Closed -$353K
ENS icon
1075
EnerSys
ENS
$7.01B
-1,541
Closed -$226K

Similar funds

AXQ Capital's Q1 2026 Portfolio in Review

As of Q1 2026, AXQ Capital held 1,320 positions worth $777M, up 75% from $443M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

AXQ Capital deployed $396M of net new capital in Q1 2026, opening 618 new positions and adding to 231 existing holdings. Its largest new stake was TPG: 111,339 shares worth $4.51M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Stryker, an estimated $2.04M trimmed.

  • AXQ Capital's largest Q1 2026 buy was TPG: 111,339 shares worth $4.51M.
  • AXQ Capital added most to Boston Scientific in Q1 2026, an estimated $7M increase.
  • AXQ Capital's biggest Q1 2026 reduction was Stryker, cutting an estimated $2.04M.
  • AXQ Capital fully exited Marsh in Q1 2026, selling an estimated $2.55M.
  • AXQ Capital's ten largest holdings make up 6.3% of its $777M portfolio in Q1 2026.
  • AXQ Capital opened 618 new positions and closed 347 in Q1 2026.
  • AXQ Capital's portfolio value rose 75% quarter-over-quarter to $777M.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.